4D Molecular Therapeutics Inc (FDMT)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $689.52M
Last updated: Nov 17, 2026 at 4:33 PM ET
4D Molecular Therapeutics Inc (FDMT) Stock Chart
4D Molecular Therapeutics (FDMT) has a latest price of $10.79 on Nov 17, 2026, 36.3% below its 52-week high of $16.93. Its price was flat over the past 12 months. The month-end price fell 50.5% over the 5 years through Oct 2026, a compound annual decline of 13.1%.
Price Chart
From Dec 2020 to Oct 2026, its highest month-end close was $43.38 in Mar 2021 and its lowest $3.23 in Mar 2025, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart FDMT with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for FDMT.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 35.6%, and over 6 months it rose 28.4%. The month-end price rose 10.8% over the 3 years through Oct 2026, a compound annual rate of 3.5%.
| Period | Change |
|---|---|
| 1 month | -12.2% |
| 3 months | -35.6% |
| 6 months | +28.4% |
| 12 months | 0.0% |
| 12 months, with dividends | 0.0% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +10.8% | +3.5% |
| 5 years | -50.5% | -13.1% |
Price by Year
Its best calendar year was 2025, when the price rose 34.6%, and its weakest was 2024, when it fell 72.5%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $11.90 | +58.7% |
| 2025 | $7.50 | +34.6% |
| 2024 | $5.57 | -72.5% |
| 2023 | $20.26 | -8.8% |
| 2022 | $22.21 | +1.2% |
| 2021 | $21.94 | -47.1% |
Trading Range
The price is 16.9% below its 50-day average of $12.99 and 2.8% below its 200-day average of $11.10.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $10.79 | |
| 52-week high | $16.93 | -36.3% |
| 52-week low | $6.96 | +55.0% |
| 50-day average | $12.99 | -16.9% |
| 200-day average | $11.10 | -2.8% |
Price Risk
Over 3 years, its largest fall from a peak was 93.0%.
| Measure | Value |
|---|---|
| 1-year beta | 1.96 |
| Largest fall, 1 year | -38.3% |
| Largest fall, 3 years | -93.0% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About FDMT
What is FDMT's 1-year price change?
4D Molecular Therapeutics's price was flat over the past 12 months. With dividends included, the 12-month total return was 0.0%.
What is FDMT's 5-year price change?
4D Molecular Therapeutics's month-end price fell 50.5% over the 5 years through Oct 2026, a compound annual decline of 13.1%. These figures leave out dividends.
What is FDMT's 52-week high and low?
4D Molecular Therapeutics's 52-week high is $16.93 and its 52-week low is $6.96. Its latest price of $10.79 on Nov 17, 2026 is 36.3% below the high.
What is FDMT's beta?
4D Molecular Therapeutics's 1-year beta against the S&P 500 is 1.96, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 38.3%.
Is the FDMT chart free?
Yes. Advanced Charting for FDMT is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
FDMT pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors